Cannabis use among teenagers is linked to delayed cognitive development and worse memory over time, the largest US study to date showed.
In an analysis of over 11,000 teenagers, cannabis use was associated with reduced improvement in memory, attention, language, and processing speed, compared to adolescents who did not use cannabis.
When researchers zeroed in on specific cannabis components, they found that those who used tetrahydrocannabinol (THC) showed worse memory as they grew older, compared to nonusers.
“Adolescence is a critical time for brain development, and what we’re seeing is that teens who start using cannabis aren’t improving at the same rate as their peers,” lead author Natasha Wade, PhD, and assistant professor of psychiatry at UC San Diego School of Medicine, said in a news release. “These differences may seem small at first, but they can add up in ways that affect learning, memory and everyday functioning.”
The study was published online April 20th in Neuropsychopharmacology.
Key Window of Brain Development
Over the past few decades, the number of teenagers using cannabis has remained high, with an estimated 1 in 5 high schoolers using cannabis. Cannabis potency has also increased significantly over time, raising concerns over the risk of heightened adverse effects, particularly for younger users.
During adolescence, cannabis exposure may disrupt brain development and is associated with a significantly higher likelihood of incident psychiatric disorders and worse academic performance.
To gain a comprehensive picture of the effects of cannabis use on neurocognitive trajectories in this age group, the investigators included 11,036 teenagers (47% female) in their analysis. Teens were recruited at ages 9-10 years from 21 sites across the US and followed for over 10 years.
They were interviewed about their past-year substance use at annual follow-ups, along with a mid-year assessment. Caregivers were questioned about their child’s medicinal cannabidiol (CBD) use. The investigators combined this self-report data with toxicological testing on participants’ hair, urine, and saliva throughout the study.
Participants inhibitory control were assessed by the Flanker Inhibitory Control and Attention task, and receptive language was tested by having participants listen to a word and match it to a picture. To evaluate their visuospatial performance, participants were asked to identify the correct location of an item in various orientations. Verbal recall and memory were assessed using the Rey Auditory Verbal Learning Test. Other tasks assessed participants’ oral reading, processing speed, working memory, and episodic memory.
Covariates included age, sex, lifetime substance use, sociodemographic factors, family history of substance use, and prenatal substance exposure.
Findings Over Time
Initially, teen cannabis users’ working memory performance appeared to be better than nonusers. However, as they got older, their improvement slowed relative to controls and at age 17, cannabis use was associated with worse performance (P = .0001).
At ages 9 and 10, cannabis user’s inhibitory control was superior to controls (P < .01 for both). Over time, this relationship flipped such that by ages 15-17, users’ inhibitory control was worse (P < .0001 for all ages).
The same trend over time was shown for teen cannabis users’ processing speed, oral reading, episodic memory, receptive language, verbal recall, and visuospatial performance, culminating with statistically significant worse performance at ages 15-17.
Secondary hair analyses showed that THC was linked to a lower rate of episodic memory improvement (P = .007). At ages 15-17, THC teens showed worse episodic memory than controls and CBD teens.
“These results point to THC as a likely driver of the changes we’re seeing,” Wade said. “It also highlights how complicated cannabis products can be, especially since some products labeled as CBD may still contain THC.”
However, the authors also noted that this finding should be interpreted cautiously as the CBD positive subsample consisted of just 21 participants. There were no significant relationships found for the other neurocognitive tasks in this secondary hair analysis.
“Findings support interventions aimed at delaying cannabis initiation during early adolescence and integrating neuroscience-informed psychoeducation about cognitive development during sensitive periods,” the investigators wrote.
Limitations of the study were possible selection bias that may reduce generalizability and potential external contamination of hair samples.
The ABCD Study is supported by the National Institutes of Health and additional federal partners. The authors declared no competing interests.